<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study</article-title>
</title-group>
